Trials / Unknown
UnknownNCT04298528
A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint Arthroplasty
A Prospective, Randomized, Double Blind Trial Comparing Dronabinol to a Placebo in the Management of Post-operative Pain in Total Joint Arthroplasty
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 460 (estimated)
- Sponsor
- Colorado Joint Replacement · Academic / Other
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study was to determine if cannabinoid use decreases narcotic consumption in patients undergoing total knee arthroplasty (TKA).
Detailed description
Subjects enrolled will be randomized into one of two groups either receiving the study drug or a placebo and will be followed for the first 6 weeks with regards to outcomes data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dronabinol | 2.5mg 2 times a day for 30 days after total knee replacement |
| OTHER | Placebo | 2 times a day for 30 days after total knee replacement |
Timeline
- Start date
- 2020-02-05
- Primary completion
- 2024-02-05
- Completion
- 2025-02-05
- First posted
- 2020-03-06
- Last updated
- 2023-01-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04298528. Inclusion in this directory is not an endorsement.